Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Autoimmune Disorders

Free Subscription 17.09.2018 1 BMC Neurol 1 Brain 2 Diabetes Res Clin Pract 1 Intern Med 1 J Autoimmun 1 J Immunol 14 J Neuroimmunol 2 J Neurol 2 Lancet Diabetes Endocrinol 3 N Engl J Med 2 Neurology 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMC Neurol

1. CABECA HLS, Rocha LC, Sabba AF, Tomas AM, et al
   The subtleties of cognitive decline in multiple sclerosis: an exploratory study using hierarchichal cluster analysis of CANTAB results.
   BMC Neurol. 2018;18:140.
   PubMed     Text format     Abstract available
   
   

   
   Brain

2. BAKER D, Pryce G, Amor S, Giovannoni G, et al
   Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis.
   Brain. 2018 Sep 12. pii: 5095715. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Diabetes Res Clin Pract

3. MKRTUMYAN A, Romantsova T, Vorobiev S, Volkova A, et al
   Efficacy and safety of Subetta add-on therapy in type 1 diabetes mellitus: The results of a multicenter, double-blind, placebo-controlled, randomized clinical trial.
   Diabetes Res Clin Pract. 2018;142:1-9.
   PubMed     Text format     Abstract available
   
   
4. ZURAWEK M, Dzikiewicz-Krawczyk A, Izykowska K, Ziolkowska-Suchanek I, et al
   miR-487a-3p upregulated in type 1 diabetes targets CTLA4 and FOXO3.
   Diabetes Res Clin Pract. 2018;142:146-153.
   PubMed     Text format     Abstract available
   
   

   
   Intern Med

5. ARITOMI T, Kido T, Nakano K, Satoh Y, et al
   A Case of a Small Cell Lung Cancer Patient with Anti-transcriptional Intermediary Factor 1gamma Antibody Who Developed Dermatomyositis after Successful Chemoradiotherapy.
   Intern Med. 2018 Sep 12. doi: 10.2169/internalmedicine.1007.
   PubMed     Text format     Abstract available
   
   

   
   J Autoimmun

6. THIEL J, Alter C, Luppus S, Eckstein A, et al
   MicroRNA-183 and microRNA-96 are associated with autoimmune responses by regulating T cell activation.
   J Autoimmun. 2018 Sep 7. pii: S0896-8411(18)30302.
   PubMed     Text format     Abstract available
   
   

   
   J Immunol

7. HAMILTON JA, Wu Q, Yang P, Luo B, et al
   Cutting Edge: Intracellular IFN-beta and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells.
   J Immunol. 2018 Sep 10. pii: jimmunol.1800791. doi: 10.4049/jimmunol.1800791.
   PubMed     Text format     Abstract available
   
   

   
   J Neuroimmunol

8. HAARMANN A, Hahnel L, Schuhmann MK, Buttmann M, et al
   Age-adjusted CSF beta2-microglobulin and lactate are increased and ACE is decreased in patients with multiple sclerosis, but only lactate correlates with clinical disease duration and severity.
   J Neuroimmunol. 2018;323:19-27.
   PubMed     Text format     Abstract available
   
   
9. SHAKERIAN L, Ghorbani S, Talebi F, Noorbakhsh F, et al
   MicroRNA-150 targets PU.1 and regulates macrophage differentiation and function in experimental autoimmune encephalomyelitis.
   J Neuroimmunol. 2018;323:167-174.
   PubMed     Text format     Abstract available
   
   
10. DEBNATH M, Nagappa M, Subbanna M, Sundaravadivel P, et al
    Th17 pathway signatures in a large Indian cohort of Guillain Barre syndrome.
    J Neuroimmunol. 2018;323:125-130.
    PubMed     Text format     Abstract available
    
    
11. BLUM S, Ji Y, Pennisi D, Li Z, et al
    Genome-wide association study in Guillain-Barre syndrome.
    J Neuroimmunol. 2018;323:109-114.
    PubMed     Text format     Abstract available
    
    
12. AMORUSO A, Blonda M, D'Arrigo G, Grasso R, et al
    Effect of fingolimod action on the release of monocyte-derived microvesicles in multiple sclerosis patients.
    J Neuroimmunol. 2018;323:43-48.
    PubMed     Text format     Abstract available
    
    
13. MOHAMMADZADEH A, Rad IA, Ahmadi-Salmasi B
    CTLA-4, PD-1 and TIM-3 expression predominantly downregulated in MS patients.
    J Neuroimmunol. 2018;323:105-108.
    PubMed     Text format     Abstract available
    
    
14. HOCAOGLU M, Durmus H, Ozkan B, Yentur SP, et al
    Increased costimulatory molecule expression of thymic and peripheral B cells and a sensitivity to IL-21 in myasthenia gravis.
    J Neuroimmunol. 2018;323:36-42.
    PubMed     Text format     Abstract available
    
    
15. SLAVIN YN, Bo M, Caggiu E, Sechi G, et al
    High levels of antibodies against PtpA and PknG secreted by Mycobacterium avium ssp. paratuberculosis are present in neuromyelitis optica spectrum disorder and multiple sclerosis patients.
    J Neuroimmunol. 2018;323:49-52.
    PubMed     Text format     Abstract available
    
    
16. DUBEY D, Hussain RZ, Miller-Little WA, Salter A, et al
    PDCB does not promote CNS autoimmunity in the context of genetic susceptibility but worsens its outcome.
    J Neuroimmunol. 2018;323:53-55.
    PubMed     Text format     Abstract available
    
    
17. DUBEY D, Kothapalli N, McKeon A, Flanagan EP, et al
    Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction.
    J Neuroimmunol. 2018;323:62-72.
    PubMed     Text format     Abstract available
    
    
18. KVISTAD SS, Myhr KM, Holmoy T, Benth JS, et al
    Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis.
    J Neuroimmunol. 2018;323:73-77.
    PubMed     Text format     Abstract available
    
    
19. ROSSETTI I, Zambusi L, Finardi A, Bodini A, et al
    Calcitonin gene-related peptide decreases IL-1beta, IL-6 as well as Ym1, Arg1, CD163 expression in a brain tissue context-dependent manner while ameliorating experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2018;323:94-104.
    PubMed     Text format     Abstract available
    
    
20. HOU H, Cao R, Quan M, Sun Y, et al
    Rapamycin and fingolimod modulate Treg/Th17 cells in experimental autoimmune encephalomyelitis by regulating the Akt-mTOR and MAPK/ERK pathways.
    J Neuroimmunol. 2018;324:26-34.
    PubMed     Text format     Abstract available
    
    
21. KOSTIC M, Zivkovic N, Cvetanovic A, Stojanovic I, et al
    Granulocyte-macrophage colony-stimulating factor as a mediator of autoimmunity in multiple sclerosis.
    J Neuroimmunol. 2018;323:1-9.
    PubMed     Text format     Abstract available
    
    

    
    J Neurol

22. FAKIH R, Matiello M, Chitnis T, Stankiewicz JM, et al
    Efficacy and safety of mycophenolate mofetil in progressive multiple sclerosis patients.
    J Neurol. 2018 Sep 10. pii: 10.1007/s00415-018-9050.
    PubMed     Text format     Abstract available
    
    
23. GAETANI L, Prosperini L, Mancini A, Eusebi P, et al
    2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes.
    J Neurol. 2018 Sep 8. pii: 10.1007/s00415-018-9048.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Diabetes Endocrinol

24. DANDONA P, Mathieu C, Phillip M, Hansen L, et al
    Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
    Lancet Diabetes Endocrinol. 2017 Sep 13. pii: S2213-8587(17)30308.
    PubMed     Text format     Abstract available
    
    
25. DAHLQVIST S, Rosengren A, Gudbjornsdottir S, Pivodic A, et al
    Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study.
    Lancet Diabetes Endocrinol. 2017 Aug 21. pii: S2213-8587(17)30262.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

26. ANTEL J
    Therapy in Multiple Sclerosis - Coming of Age.
    N Engl J Med. 2018;379:1085-1086.
    PubMed     Text format    
    
    
27. GORMAN MP, Gombolay GY, Mehan WA Jr, Thibert RL, et al
    Case 27-2018: A 3-Year-Old Boy with Seizures.
    N Engl J Med. 2018;379:870-878.
    PubMed     Text format    
    
    
28. CHITNIS T, Arnold DL, Banwell B, Bruck W, et al
    Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
    N Engl J Med. 2018;379:1017-1027.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

29. FERREIRA DA SILVA IR, Frontera JA, Moreira do Nascimento OJ
    News from the battlefront: Zika virus-associated Guillain-BarrE Syndrome in Brazil.
    Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000003024.
    PubMed     Text format    
    
    
30. 
    Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
    Neurology. 2018;91:538.
    PubMed     Text format    
    
    

    
    Proc Natl Acad Sci U S A

31. HAUSLER D, Hausser-Kinzel S, Feldmann L, Torke S, et al
    Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease.
    Proc Natl Acad Sci U S A. 2018 Sep 7. pii: 1810470115.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: